Related Experiment Video
Updated: Jul 25, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Treatment-induced blood pressure reduction and the risk of myocardial infarction
M H Alderman1, W L Ooi, S Madhavan
1Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10461.
Insights
Achieving a moderate reduction in diastolic blood pressure (BP) may lower the risk of myocardial infarction in mild to moderate hypertensives. Both large and small BP drops were linked to increased heart attack risk compared to moderate declines.
Area of Science:
- Cardiology
- Hypertension Management
Background:
- Mild to moderate hypertension affects a significant population, necessitating effective treatment strategies.
- The relationship between the degree of blood pressure reduction and cardiovascular outcomes like myocardial infarction requires further elucidation.
Purpose of the Study:
- To investigate the association between the extent of treatment-induced blood pressure reduction and the incidence of myocardial infarction in previously untreated individuals with mild to moderate hypertension.
Main Methods:
- A cohort of 1765 untreated patients with mild to moderate hypertension was reviewed.
- Diastolic blood pressure (BP) reduction was categorized into small (≤6 mm Hg), moderate (7–17 mm Hg), and large (≥18 mm Hg) changes.
- Cox regression analysis was employed to assess the relationship between BP reduction categories and myocardial infarction events.
Main Results:
- Over an average follow-up of 4.2 years, 39 myocardial infarctions occurred.
- Both large and small reductions in diastolic BP were associated with a higher incidence of myocardial infarction compared to a moderate decline.
- Age and sex were identified as independent risk factors for myocardial infarction, while other factors like BMI and cholesterol were not significant.
Conclusions:
- A moderate reduction in diastolic blood pressure may be an optimal treatment goal for patients with mild to moderate hypertension to minimize myocardial infarction risk.
- The study suggests a non-linear relationship between diastolic BP reduction and cardiovascular events.
Abstract:
To examine the relationship between degree of treatment-induced blood pressure (BP) reduction and myocardial infarction, the experience of 1765 previously untreated, mild to moderate hypertensives (initial BP greater than or equal to 160 and/or greater than or equal to 95 mm Hg) in a systematic treatment program was reviewed. Over an average of 4.2 years, there were 39 morbid or fatal myocardial infarctions. Three types of fall in diastolic BP (final minus pretreatment) were defined: small (less than or equal to 6 mm Hg), moderate (7 to 17 mm Hg), and large (greater than or equal to 18 mm Hg). By Cox regression, an association was observed between myocardial infarctions and both a large and a small fall, relative to a moderate decline. Age and sex were independent risk factors. Body mass index, cholesterol level, electrocardiogram, race, prior cardiovascular disease, smoking status, initial and final revisit BP, total intreatment BP, and systolic BP were not. Since both a large and small reduction in diastolic BP were associated with a higher incidence of myocardial infarction (relative to a moderate fall), perhaps a moderate reduction in diastolic BP should be the goal of treatment for mild and moderate hypertensives.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Myocarditis III: Medical Management
Angina IV: Management
Atherosclerosis III: Management